Disruption of differentiation in human cancer: AML shows the way
By Daniel G. Tenen. Nature Reviews. Cancer, 2003
689 citations recorded by the source corpus.
Subfields: Hematology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/e4f55471ff03a276f417ad96412cefe4755736a0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Hematology
- J. Dick
- Frank Rosenbauer
- Jean C. Y. Wang
- M. Greaves
- Joe Wiemels
- Benjamin L. Ebert
- E. Laurenti
- Daniel G. Tenen
In Molecular Biology
- J. Dick
- Frank Rosenbauer
- M. Greaves
- Joe Wiemels
- Jean C. Y. Wang
- Levi Waldron
- Benjamin L. Ebert
- Igor Jurisica
Citations in the corpus
- Cancer stem cells: lessons from leukemia. (2005, background): “This concept is supported by a correlation between genes required for normal hematopoietic development and those perturbed in leukemia [ 23 ] and by the recent demonstration that Bmi-1 is required for selfrenewal of both normal and leukemic HSCs in mice [24,25].”
- Hematopoiesis: a human perspective. (2012, background): “A detailed description of these and other molecular pathways implicated in hematological disorders is the subject of a number of excellent reviews (Tenen, 2003).”
- Phosphorylation of C/EBPα Inhibits Granulopoiesis (2004, background): “Thus, multiple mechanisms that result in inhibition of C/EBP protein function contribute to myeloid leukemias ( 44 ).”
- Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis (2015, neutral): “Arising from the disruption of regulated myeloid differentiation (Tenen, 2003), AML results in a disordered developmental hierarchy wherein leukemic stem cells (LSCs) are capable of re-establishing the disease in immunodeficient mice (Bonnet and Dick, 1997).”
- Transcription factors in myeloid development: balancing differentiation with transformation (2007, background): “Furthermore, dysregulation of transcription factor activity has an important role in leukaemia, implicating these genes as potential targets for therapeutic intervention in myeloid and other cancer”
- Stem cell gene expression programs influence clinical outcome in human leukemia (2011, background): “In AML, stem cell regulation and differentiation are abnormal; self-renewal is much greater in LSCs than in HSCs, and differentiation is deregulated and highly variable among genetic and morphological subtype”
- Origins of chromosome translocations in childhood leukaemia (2003, background): “These same genes are crucial for the normal function of haematopoietic stem cells, as shown by knockout experiments in mic”